← Dashboard
Aug 25, 2026 02:35 PM ET
Catalyst
FDA/Bio
MODERNA EXTENDS GAINS AS WOLFE UPGRADES ON TRIAL WIN FOR CANCER THERAPY - SEEKINGALPHA
Wolfe upgrade and trial win for cancer therapy drive Moderna's extended gains.
What changed
Why it matters
Wolfe upgrade and trial win for cancer therapy drive Moderna's extended gains.
Sources
seekingalpha
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →
PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →
UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →